PHA 408
PHA 408 (PHA-408) is a potent, selective and orally active IκB kinase-2 (IKK-2) inhibitor. PHA 408 is a powerful anti-inflammatory agent against lipopolysaccharide (LPS) - and cigarette smoke (CS) -mediated lung inflammation[1].
Product Specifications
CAS Number
503555-55-3
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
IKK
Type
Reference compound
Related Pathways
NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/pha-408.html
Purity
99.40
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(C1=NN(C2=CC=C(F)C=C2)C3=C1CCC4=CC=C(NC(C5=C(Cl)C=NC(N6CCN(C)CC6)=C5)=O)C=C43)N
Molecular Formula
C29H27ClFN7O2
Molecular Weight
560.02
Precautions
H315, H319, H335
References & Citations
[1]Rajendrasozhan S, et al. Anti-inflammatory effect of a selective IkappaB kinase-beta inhibitor in rat lung in response to LPS and cigarette smoke. Pulm Pharmacol Ther. 2010 Jun;23 (3) :172-81.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IKK-β
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS8430738-02 5x 0.1 mg
CD200 Recombinant Protein His Tag Lyophilized
Sign In for Pricing
View Details 
C8376-01-ML405 100 µL
CXCR6, Bonzo, NT (STRL33, TYMSTR) (MaxLight 405) discontinued
Sign In for Pricing
View Details